Active Ingredient(s): Avatrombopag Maleate
FDA Approved: * May 21, 2018
Pharm Company: * AKARX INC
Category: Blood Volume

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Doptelet Overview

Avatrombopag, sold under the brand name Doptelet, is a medication that used for certain conditions that lead to thrombocytopenia (low platelets) such as thrombocytopenia associated with chronic liver disease in adults who are to undergo a planned medical or dental procedure. It was approved for medical use in the United States in 2018,[1][2] and in the European Union in 2019.[3] References .mw-parser-output .reflist{font-size:90%;margin-bott...

Read more Doptelet Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Doptelet Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Avatrombopag Maleate
  • Tablet: 20mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Doptelet: (1 result)

Sorted by National Drug Code
  • 71369-020 Doptelet 20 mg Oral Tablet, Film Coated by Akarx, Inc.

Other drugs which contain Avatrombopag Maleate or a similar ingredient: (1 result)